Table 3 Levels of thrombophilic risk factors in patients with central retinal artery occlusion and controls
From: High prevalence of thrombophilic risk factors in patients with central retinal artery occlusion
Thrombophilic risk factor | CRAO group n = 126 | Control group n = 107 | p-value |
|---|---|---|---|
Protein C activity, % | 102.2 (82.1–117.7) | 104.8 (89.5–124.8) | 0.17 |
Free protein S level, % | 90.7 (78.2–111.8) | 90.2 (80.3–106.8) | 0.66 |
Antithrombin activity, % | 98.9 (86.4–111.1) | 96.8 (82.4–108.6) | 0.62 |
Factor VIII activity, % | 121.6 (103.3–147.7) | 108.9 (90.6–138.4) | 0.016* |
Homocysteine, µmol/l | 13.1 (10.2–15.2) | 10.6 (9.4–13.5) | < 0.001* |
Anticardiolipin antibodies IgM, MPL | 8.2 (4.1–14.9) | 6.4 (4.5–7.9) | < 0.001* |
Anticardiolipin antibodies IgG, GPL | 7.9 (3.5–12.5) | 5.4 (3.5–7.7) | < 0.001* |
Anti-beta-2-glycoprotein I antibodies IgM, SMU | 11.4 (7.2–16.2) | 6.8 (4.9–8.9) | < 0.001* |
Anti-beta-2-glycoprotein I antibodies IgG, SGU | 10.9 (7.4–13.9) | 6.9 (4.9–8.6) | < 0.001* |